Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-05-28
1997-12-09
Jarvis, William R.A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514318, 514330, 514 12, A61K 31445, A61K 3818
Patent
active
056961359
ABSTRACT:
This invention relates to the method of using neurotrophic pipecolic acid derivative compounds having an affinity for FKBP-type immunophilins as inhibitors of the enzyme activity associated with immunophilin proteins, and particularly inhibitors of peptidyl-prolyl isomerase or rotamase enzyme activity to stimulate or promote neuronal growth or regeneration.
REFERENCES:
patent: 4310461 (1982-01-01), Krapcho et al.
patent: 4390695 (1983-06-01), Krapcho et al.
patent: 4531964 (1985-07-01), Shimano et al.
patent: 4578474 (1986-03-01), Krapcho et al.
patent: 4593102 (1986-06-01), Shanklin, Jr.
patent: 5192773 (1993-03-01), Armistead et al.
patent: 5330993 (1994-07-01), Armistead et al.
patent: 5385918 (1995-01-01), Connell et al.
patent: 5414083 (1995-05-01), Hackl et al.
patent: 5516797 (1996-05-01), Armistead et al.
patent: 5543423 (1996-08-01), Zelle et al.
Burbaum, Chemical Abstract, vol. 123:170197, 1995.
Burbaum, Chemical Abstract, vol. 121:109686, 1994.
Armistead, Chemical Abstract, vol. 121:170549, 1994.
Armistead, chemical Abstract, vol. 117:131071, 1992.
Holt, Chemical Abstract, vol. 125:86501, 1996.
Smith, Chemical Abstract, vol. 125:114400, 1996.
Baker, chemical Abstract, vol. 123:313433, 1995.
Camaggi, Chemical Abstract, vol. 124:30417, 1995.
Armistead, Chemical Abstract, vol. 122:55896, 1994.
Skotnicki, Chemical Abstract, vol. 120:54388, 1993.
Luethy, Chemical Abstract, vol. 123:313999, 1993.
Frenette, Chemical Abstract, vol. 121:35325, 1993.
Krantz, Chemical Abstract, vol. 120:245776, 1993.
Ito, Chemical Abstract, vol. 120:245780, 1993.
Casini, Chemical Abstract, vol. 120:270095, 1993.
Armistead, Chemical Abstract, vol. 119:95338, 1992.
Goulet, Chemical Abstract, vol. 118:80723, 1992.
Kasahara, Chemical Abstract, vol. 117:48221, 1992.
Long, Chemical Abstract, vol. 118:169119, 1992.
Harding, M.W., et al. "A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase," Nature Lett., 1989, 341, 758-60.
Ponticelli, Claudio, "Treatment of the Nephrotic Syndrome with Cyclosporin A," J. of Autoimmunity, 1992, 5, 315.
Tindall, Richard S.A., "Immunointervention with Cyclosporin A in Autoimmune Neurological Disorders," J. of Autoimmunity, 1992, 5, 301.
Tugwell, Peter, "Cyclosporin in the Treatment of Rheumatoid Arthritis," J. of Autoimmunity, 1992, 5, 231-40.
Fry, Lionel, "Psoriasis: Immunopathology and Long-term treatment with Cyclosporin," J. of Autoimmunity, 1992, 5, 277-83.
Feutren, Gilles, "The Optimal use of Cyclosporin A in Autoimmune Diseases," J. of Autoimmunity, 1992, 5, 183-95.
Kaczmar, et al., Makromol. Chem., 1976, 177, 1981-9.
Steiner, Joseph P. et al., "High brain densities of the immunophilin FKBP colocalized with calcineurin," Nature Lett., 1992, 358, 584-7.
Dawson, Ted M. et al., "Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity," Proc. Natl. Acad. Sci. USA, 1993, 90, 9808-12.
Caufield, Craig E. and Musser, John H., Annual Reports in Medicinal Chemistry, Johns (Ed.), Academic Press, Inc., Chapter 21, 195-204, 1989.
Nakatsuta, M. et al. "Total Synthesis of FK506 and an FKBP Probe Reagent, (C.sub.8, C.sub.9 -.sup.13 C.sub.2) -FK-506," J. Am. Chem. Soc., 1990, 112 (14), 5583-90.
Dawson, T.M. et al., "The immunophilins, FK506 Binding Protein and Cyclophilin, are Discretely Localized in the Brain: Relationship to Calcineurin," Neuroscience, 1994, 62(2), 569-80.
Cameron, Andrew et al., "Immunophilin FK506 binding protein associated with inositol 1,4,5-trisphosphate receptor modulates calcium flux," Proc. Natl. Acad. Sci. USA, 1995, 92, 1784-88.
Steiner, J.P. et al., "Nonimmunosuppressive Ligands for Neuroimmunophilins Promote Nerve Extension In Vitro and In Vivo," Society for Neuroscience Abstracts, 1996, 22, 297.13.
Lyons, W. Ernest et al., "Neuronal Regeneration Enhances the Expression of the Immunophilin FKBP-12," The Journal of Neuroscience, 1995, 15, 2985-94.
Hayward, C.M., et al., "An application of the Suarez reaction to the regiospecific synthesis of the C.sub.28 -C.sub.42 segment of rapamycin," 1993, 3989-92.
Hovarth, R. et al., "An application of the Evans-Prasad 1,3-Syn diol synthesis to a stereospecific synthesis of the C.sub.10 -C.sub.27 segment of rapamycin," Tetrahedron Lett., 1993, 34(25), 3993-3996.
Whitesell, J.K. et al., "Asymmetric Induction. Reduction, Nucleophilic Addition to, Ene Reactions of Chiral .alpha.-Ketoesters," J. Chem. Soc., Chem Commun., 1983, 802.
Kino, Toru et al., "FK-506, A novel immunosuppressant isolated from A Streptomyces," J. of Antibiotics, 1987, 40(9), 1249-55.
Hauske, James R. et al., "Design and Synthesis of Novel FKBP Inhibitors," J. Med. Chem., 1992, 35, pp. 4284-4296.
Holt, Dennis A. et al., "Structure-Activity Studies of Nonmacrocyclic Rapamycin Derivatives," Bioorganic & Medical Chemistry Letters, 1993, vol. 3, No.10, pp. 1977-1980.
Yamashita, Dennis S. et al., "Design Synthesis and Evaluuation of Dual Domain FKBP Ligands," Bioorganic & Medicinal Chemistry Letters, 1994, vol. 4, No. 2 pp. 325-328.
Teague, Simon J. et al., "Synthesis and Study of a Non Macrocyclic FK506 Derivative," Bioorganic & Medical Chemistry Letters, 1994, vol. 4, No. 13, pp. 1581-1584.
Luengo, Juan I. et al., "Synthesis and Structure-Activity Relationship of Macrocyclic FKBP Ligands," Bioorganic & Medicinal Chemistry Letters, 1994, vol. 4, No. 2, pp. 321-324.
Holt, Dennis A. et al., "Structure-Activity Studies of Synthetic FKBP Ligands as Peptidyl-Prolyl Isomerase Inhibitors," Bioorganic & Medicinal Chemistry Letters, 1994, vol. 4, No. 2, pp. 315-320.
Teague, Simon J. et al., "The Affinity of the Excised Binding Dommain of FK-506 for the Immunophilin FKBP12," Bioorganic & Medicinal Chemistry Letters, 1993, vol. 3, No. 10, pp. 1947-1950.
Caffrey, Moya V. et al., "Synthesis and Evaluation of Dual Domain Macrocyclic FKBP12 Ligands," Bioorganic & Medicinal Chemistry Letters, 1994, vol. 4, No. 21, pp. 2507-2510.
Birkenshaw, Timothy N. et al., "Synthetic FKBP12 Ligands. Design and Synthesis of Pyranose Replacements," Bioorganic & Medicinal Chemistry Letters, 1994, vol. 4, No. 21, pp. 2501-2506.
Holt, Dennis A. et al., "Design, Synthesis, and Kinetic Evaluation of High-Affinity FKBP Ligands and the X-ray Crystal Structures of Their Complexes with FKBP12," J. Am. Chem. Soc., 1993, 115, pp. 9925-9938.
Wang, Gary T. et al., "Synthesis and FKBP Binding of Small Molecule Mimics of the Tricarbonyl Region of FK506," Bioorganic & Medicinal Chemistry Letters, 1994, vol. 4, No. 9, pp. 1161-1166.
Snyder, Solomon H. and Sabatini, David M., "Immunophilins and the Nervous System," Nature Medicine, 1995, vol. 1, No. 1, pp. 32-37.
Stocks, Michael J. et al., "The Contribution to Binding of the Pyranoside Substitutents in the Excised Binding Domain of FK-506," Bioorganic & Medicinal Chemistry Letters, 1994, vol. 4, No. 12, pp. 1457-1460.
Chakraborty, Chemical Abstract, vol. 125:115111, 1996.
Shu, Chemical Abstract, vol. 124:342921, 1996.
Chakraborty, Chemical Abstract, vol. 124:290256, 1996.
Slee, Chemical Abstract, vol. 124:105570, 1995.
Tatlock, Chemical Abstract, vol. 124:86677, 1995.
Teague, Chemical Abstract, vol. 124:29474, 1995.
Stocks, Chemical Abstract, vol. 124:29735, 1995.
Wang, Chemical Abstract, vol. 123:275108, 1995.
Nicolaou, Chemical Abstract, vol. 123:285602, 1995.
Armistead, Chemical Abstract, vol. 123:217939, 1995.
Luengo, Chemical Abstract, vol. 123:187705, 1995.
Furber, Chemical Abstract, vol. 123:47577, 1995.
Chakraborty, Chemical Abstract, vol. 123:74408, 1995.
Wang, Chemical Abstract, vol. 123:74101, 1995.
Smith, Chemical Abstract, vol. 123:55541, 1995.
Baumann, Chemical Abstract, vol. 122:314327, 1995.
Nelson, Chemical Abstract, vol. 122:80964, 1994.
Caffrey, Chemical Abstract, vol. 123:82999, 1994.
Birkenshaw, Chemical Abstract, vol. 122:187213, 1994.
Hauske, Chemical Abstract, vol. 122L45705, 1994.
Stocks, Chemical Abstract, vol. 121:271263, 1994.
Teague, Chemical Abstract, vol. 121:255492, 1994.
Mashkovskii, Chemical Abstract, vol. 121:212542, 1993.
Ranganathan, Chemical Abstract, vol. 121:205990, 1994.
Wang, Chemical Abstract, vol. 121:170041, 199
Hamilton Gregory S.
Snyder Solomon
Steiner Joseph P.
GPI Nil Holdings Inc.
Jarvis William R.A.
Johns Hopkins Univ. School of Medicines
Juneau Todd L.
Nath Gary M.
LandOfFree
Inhibitors of rotamase enzyme activity effective at stimulating does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibitors of rotamase enzyme activity effective at stimulating , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of rotamase enzyme activity effective at stimulating will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1608027